These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16481709)

  • 1. Chronic zosteriform cutaneous leishmaniasis.
    Omidian M; Mapar MA
    Indian J Dermatol Venereol Leprol; 2006; 72(1):41-2. PubMed ID: 16481709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study.
    Esfandiarpour I; Dabiri SH
    Int J Dermatol; 2007 Aug; 46(8):848-52. PubMed ID: 17651170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of erysipeloid cutaneous leishmaniasis: atypical and unusual clinical variant.
    Ceyhan AM; Yildirim M; Basak PY; Akkaya VB; Erturan I
    Am J Trop Med Hyg; 2008 Mar; 78(3):406-8. PubMed ID: 18337335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare variants of Cutaneous Leishmaniasis: whitlow, paronychia, and sporotrichoid.
    Iftikhar N; Bari I; Ejaz A
    Int J Dermatol; 2003 Oct; 42(10):807-9. PubMed ID: 14521695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate.
    Momeni AZ; Reiszadae MR; Aminjavaheri M
    Int J Dermatol; 2002 Jul; 41(7):441-3. PubMed ID: 12121563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erysipeloid cutaneous leishmaniasis: about a clinical observation].
    El kartouti A; Elbenaye J; Miloudi M
    Pan Afr Med J; 2015; 21():54. PubMed ID: 26405490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
    Esfandiarpour I; Alavi A
    Int J Dermatol; 2002 Aug; 41(8):521-4. PubMed ID: 12207774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of recurrent cutaneous Leishmaniasis.
    Momeni AZ; Aminjavaheri M
    Int J Dermatol; 1995 Feb; 34(2):129-33. PubMed ID: 7737774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Cutaneous Leishmaniasis with Allopurinol Plus Itraconazole in Iran.
    Mashayekhi Goyonlo V; Derakhshan Z; Darchini-Maragheh E
    Am J Trop Med Hyg; 2023 Jun; 108(6):1164-1166. PubMed ID: 37094789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.
    Layegh P; Pezeshkpoor F; Soruri AH; Naviafar P; Moghiman T
    Am J Trop Med Hyg; 2009 Feb; 80(2):172-5. PubMed ID: 19190206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial.
    Velez I; Agudelo S; Hendrickx E; Puerta J; Grogl M; Modabber F; Berman J
    Ann Intern Med; 1997 Feb; 126(3):232-6. PubMed ID: 9027276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined antimonial allopurinol therapy in mucosal leishmaniasis.
    Sampaio RN; Marchán EM; Vexenat A; Tristão RJ; Marsden PD
    Mem Inst Oswaldo Cruz; 1990; 85(3):373-4. PubMed ID: 2134714
    [No Abstract]   [Full Text] [Related]  

  • 13. Low dosage combination of meglumine antimoniate plus allopurinol as first choice treatment of infantile visceral leishmaniasis in Italy.
    di Martino L; Mantovani MP; Gradoni L; Gramiccia M; Guandalini S
    Trans R Soc Trop Med Hyg; 1990; 84(4):534-5. PubMed ID: 2091347
    [No Abstract]   [Full Text] [Related]  

  • 14. Allopurinol in the treatment of American cutaneous leishmaniasis.
    Martinez S; Marr JJ
    N Engl J Med; 1992 Mar; 326(11):741-4. PubMed ID: 1738379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis.
    Salmanpour R; Razmavar MR; Abtahi N
    Int J Dermatol; 2006 Sep; 45(9):1115-6. PubMed ID: 16961529
    [No Abstract]   [Full Text] [Related]  

  • 16. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.
    Pimentel MI; Baptista C; Rubin EF; Vasconcellos Ede C; Lyra MR; Salgueiro Mde M; Saheki MN; Rosalino CM; Madeira Mde F; Silva AF; Confort EM; Schubach Ade O
    Rev Soc Bras Med Trop; 2011; 44(2):254-6. PubMed ID: 21552747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol.
    Momeni AZ; Aminjavaheri M
    Eur J Dermatol; 2003; 13(1):40-3. PubMed ID: 12609780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of lupoid cutaneous leishmaniasis with glucantime and topical trichloroacetic acid (a case report).
    Nilforoushzadeh MA; Sadeghian G; Jaffary F; Ziaei H; Shirani-Bidabad L; Mahzoni P
    Korean J Parasitol; 2008 Sep; 46(3):175-7. PubMed ID: 18830058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Old-world leishmaniasis of the auricle.
    Skevas A; Kastanioudakis I; Bai M; Kostoula A
    Lancet; 1997 Jan; 349(9044):28-9. PubMed ID: 8988123
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.
    Asilian A; Sadeghinia A; Faghihi G; Momeni A
    Int J Dermatol; 2004 Apr; 43(4):281-3. PubMed ID: 15090013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.